Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Health Care

Health Care

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • General
  • Health Care
  • Legal
  • M&A
  • News

Illumina Faces Mounting Pressure from Regulators Over $8B Grail Acquisition

By Vandana Singh
October 9, 9:24 AM
The European Union regulators are set to order Illumina Inc (NASDAQ: ILMN) to divest its acquisition of 

ILMN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • News

Bristol Myers Squibb Strengthens Oncology Portfolio With Mirati Therapeutics’ $5B Deal

By Vandana Singh
October 9, 9:07 AM
Bristol Myers Squibb & Co (NYSE: BMY) has agreed to acquire Mirati Therapeutics Inc (NASDAQ: MRTX) for $58.00 per share in cash, for a total 

BMY

Read More
1 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • News

Best Buy To Offer Continuous Glucose Monitoring Systems, Marking Debut Of Prescription Based Medical Devices Sale

By Shivani Kumaresan
October 9, 7:54 AM
Specialty consumer electronics retailer Best Buy Co Inc (NYSE: BBY) will 

BBY

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Media
  • News

Experts Weigh In On Ozempic’s Evolving Side Effects And How To Handle Them

By Benzinga Neuro
October 9, 5:43 AM
New side effects of the ‘miracle’ weight loss drug Ozempic are emerging, causing concern among patients and healthcare professionals alike.…

NONOF

Read More
2 minute read
  • General
  • Health Care
  • News
  • Top Stories

Elon Musk Claims Ozempic Has Impacted Walmart’s Sales, Seemingly Gives Endorsement To Drug

By Bibhu Pattnaik
October 8, 5:08 PM
In a post on X last Friday, Elon Musk drew attention to the potential impact of Ozempic on food sales at major retailer Walmart Inc. (NYSE: WMT<

WMT

Read More
2 minute read
  • Equities
  • General
  • Health Care
  • Markets
  • News

Walgreens Reportedly Confronts Impending Staff Walkout — Is Your Local Pharmacy Shutting Down Next Week?

By Nabaparna Bhattacharya
October 7, 5:24 PM
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) employees, including pharmacists, technicians, and support staff, are reportedly gearing up for a 

WBA

Read More
2 minute read
  • Cannabis
  • General
  • Government
  • Health Care
  • Markets
  • News

Historic Marijuana Milestone: Georgia First In Nation Where Hundreds Of Drug Stores Will Sell Medical Cannabis

By Maureen Meehan
October 7, 4:02 PM
The Georgia Board of Pharmacy began accepting applications from nearly 120 pharmacies to provide medical marijuana products, making it the first state in the nation to allow the sale of low-dose cannabis at independent drug stores.

CSE:TRUL

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

Sutro Biopharma’s Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside

By Vandana Singh
October 6, 2:05 PM
Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside. 

IMGN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • M&A
  • News
  • Price Target
  • Rumors
  • Trading Ideas

Amgen’s Adcomm Meeting Paves Way To Launch Boost For Mirati Therapeutics’ Lung Cancer Drug: Analysts

By Vandana Singh
October 6, 12:44 PM
According to a report on Thursday, French pharma company Sanofi SA (NASDAQ: SNY) is reportedly exploring a potential acquisition of cancer drugmaker Mirati Therapeutics Inc (NASDAQ: MRTX).

AMGN

Read More
1 minute read
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B

By Vandana Singh
October 6, 9:12 AM
GSK Plc (NYSE: GSK) said it raised £885.6 million (

GSK

Posts pagination

Previous 1 … 145 146 147 … 478 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service